FARALLON CAPITAL MANAGEMENT LLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$372,539,000
+18.7%
2,164,663
-13.4%
1.74%
+35.8%
Q2 2021$313,725,000
-11.0%
2,500,000
-3.8%
1.28%
-26.9%
Q1 2021$352,586,000
+6.0%
2,600,0000.0%1.75%
-12.4%
Q4 2020$332,644,000
+13.7%
2,600,0000.0%2.00%
-1.1%
Q3 2020$292,578,000
+46.2%
2,600,000
+23.8%
2.02%
+26.4%
Q2 2020$200,067,000
+2.4%
2,100,000
-3.4%
1.60%
-4.6%
Q1 2020$195,467,000
+84.3%
2,175,000
+8.8%
1.68%
+134.4%
Q4 2019$106,040,000
+11.8%
2,000,000
-16.7%
0.72%0.0%
Q3 2019$94,824,000
-2.8%
2,400,000
+1.1%
0.72%
+12.8%
Q2 2019$97,565,000
-11.8%
2,375,0000.0%0.64%
-23.7%
Q1 2019$110,604,000
+20.9%
2,375,000
+13.1%
0.83%
+24.0%
Q4 2018$91,455,000
-13.2%
2,100,000
+14.1%
0.67%
+7.9%
Q3 2018$105,345,000
+55.0%
1,840,732
+31.4%
0.62%
+48.1%
Q2 2018$67,977,000
+24.1%
1,401,0000.0%0.42%
+10.8%
Q1 2018$54,779,000
+18.6%
1,401,000
+28.8%
0.38%
+1.1%
Q4 2017$46,175,000
+28.5%
1,088,000
+13.0%
0.38%
+17.6%
Q3 2017$35,939,000963,0000.32%
Other shareholders
ACCELERON PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders